Minimal Sedation Versus Standard Continuous Sedation After Out-of-Hospital Cardiac Arrest
Key facts
- Who runs it
- University Medical Centre Ljubljana
- Where
- Slovenia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 22 Sept 2026
- Expected to end
- Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Minimal sedation
- Standard continuous sedation
- Record updated
- 26 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age 18 years or older
- Out-of-hospital cardiac arrest of presumed cardiac cause with return of spontaneous circulation (ROSC)
- Comatose patient (FOUR score motor response below 4, or no verbal response to pain)
Who cannot take part
- Tonic-clonic seizures at randomization
- Known severe neurological impairment before cardiac arrest (CPC 3-4)
- Time from ROSC to randomization more than 6 hours
- Hypothermia (core body temperature 33 degrees C or lower at randomization)
- Extracorporeal cardiopulmonary resuscitation (E-CPR)
- Severe haemodynamic instability despite treatment: noradrenaline 0.6 micrograms/kg/min or more (or equivalent dose of another vasopressor) required to maintain MAP of 65 mmHg or more despite adequate fluid resuscitation
- Difficult ventilation: FiO2 0.8 or more or PEEP 12 cmH2O or more required to achieve SpO2 of 90% or more or PaO2 of 8.0 kPa or more, or PaCO2 above 6.5 kPa despite optimized ventilation
- Signs of raised intracranial pressure at randomization
- Proven cervical spine injury
- Pregnancy
This trial is currently available in Slovenia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Most patients resuscitated from out-of-hospital cardiac arrest (OHCA) remain comatose on hospital admission and are routinely managed with continuous sedation. Sedation facilitates temperature control, but deep and prolonged sedation is associated with longer mechanical ventilation, delirium, infections and delayed awakening. It is unknown whether minimizing sedation increases secondary hypoxic-ischemic brain injury.
Read full original descriptionShow less
This single-centre, open-label, randomized non-inferiority trial will compare a minimal sedation strategy (no continuous sedation) with standard continuous sedation in 100 comatose adults after OHCA. The primary outcome is serum neuron-specific enolase (NSE) 72 hours after return of spontaneous circulation (ROSC). Secondary outcomes include in-hospital mortality, neurological outcome at discharge, duration of mechanical ventilation and length of ICU stay.
The 2 groups in the trial
- Minimal SedationTreatment being tested
No continuous sedation. Continuous sedation is not started, or is stopped immediately after randomization. Short-acting sedatives may be given at the lowest possible dose for the shortest possible time if clinically required (procedures, agitation, escalation of hyperthermia/shivering treatment, seizures). Adequate analgesia throughout (paracetamol, metamizole, piritramide; sufentanil infusion if needed). Extubation when criteria for safe extubation are met.
- Standard Continuous SedationExisting treatment, for comparison
Continuous sedation and analgesia for at least 36 hours after cardiac arrest according to the institutional post-cardiac arrest protocol. Propofol is the first-choice sedative and sufentanil the first-choice analgesic, titrated to PSI 25-50 (Masimo) or BIS 40-60 (Medtronic). After 36 hours, sedation may be discontinued at the discretion of the treating physician.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Early Discontinuation of Sedation on Biomarkers of Hypoxic-Ischemic Brain Injury After Out-of-Hospital Cardiac Arrest: A Prospective Randomized Non-Inferiority Trial
- Record updated
- 26 October 2026